BROWNSVILLE, Texas (ValleyCentral) – A group of Brownsville researchers are working to find a pediatric respiratory syncytial virus (RSV) vaccine.
RSV is a common respiratory virus that affects children, usually caused by mild cold-like symptoms.
ValleyCentral spoke with doctors about their development of a prototype nasal spray to serve as a potential treatment.
Affecting children under the age of 2, the virus currently has no vaccine. Jhe Medical Director of Pan American Clinical Research, Christopher Romero, stated the current impacts of RSV.
“Most people recover without problems, but unfortunately it can cause serious illness… In this country alone, around 100,000 children under the age of 2 are hospitalized each year.said Christopher Romero, medical director of Pan America Clinical Research.
Romero spoke about the research group’s developments in an RSV pediatric nasal spray that is intended to work as a vaccine.
“So we are helping to conduct a clinical trial on a new vaccine to prevent RSV. This vaccine is actually needle-free and is administered through a mist in the nose,” Romero said.
The Pan American Clinical Research group has spent the past few months testing its spray.
Romero said an important step in testing is the inclusion of the Hispanic population in this study.
“To ensure that the Hispanic-Latino population is also part of the medical literature used to provide new therapies and care,” Romero said.
Brownsville Children’s Clinic president Asim Zamir said he would meet with the group of researchers soon to learn more about the potential treatment.
Zamir added that this could bring a big change when it comes to RSV treatment.
“The vaccine is going to help our kids, and it’s not only going to help those kids not get so sick and their disease, but it’s also going to help the parents not take that financial loss from them,” Zamir said.
RSV season generally aligns with flu and cold season, however, Romero said that could change.
“A concern of some experts is that as we start to enter a phase of the pandemic where people are taking their masks off, we might see a spike in rsv that we haven’t seen during the traditional rsv season,” Romero said. .
The Pan American Clinical Research group is looking for volunteers to participate in its trials.
To participate, children must have the following qualifications:
- Be between 6 and 36 months old
- To be in a good health
- Have your vaccinations up to date for your age
To make an appointment, individuals are asked to call (956) 443-0016.
Volunteers may receive monetary compensation for their participation.